170 related articles for article (PubMed ID: 31941375)
1. Long-term Effects of Skin Tearing on Outcomes After Collagenase Treatment of Dupuytren Contractures.
Zhang D; Blazar P; Benavent KA; Earp BE
Hand (N Y); 2021 Nov; 16(6):792-796. PubMed ID: 31941375
[No Abstract] [Full Text] [Related]
2. Risk Factors for Skin Tearing in Collagenase Treatment of Dupuytren Contractures.
Zhang D; Earp BE; Blazar P
J Hand Surg Am; 2019 Dec; 44(12):1021-1025. PubMed ID: 31420243
[TBL] [Abstract][Full Text] [Related]
3. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
[TBL] [Abstract][Full Text] [Related]
4. Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction.
Zhang D; Earp BE; Benavent KA; Blazar P
Plast Reconstr Surg; 2020 Nov; 146(5):1071-1079. PubMed ID: 33136952
[TBL] [Abstract][Full Text] [Related]
5. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
6. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Nayar SK; Pfisterer D; Ingari JV
Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
[TBL] [Abstract][Full Text] [Related]
7. Patient Preferences for Limited Fasciectomy Versus Collagenase Treatment for Dupuytren Contracture.
Zhang D; Blazar P; Benavent KA; Earp BE
J Hand Surg Asian Pac Vol; 2022 Apr; 27(2):242-247. PubMed ID: 35404200
[No Abstract] [Full Text] [Related]
8. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Hwee YK; Park D; Vinas M; Litts C; Friedman D
Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures.
David M; Smith G; Pinder R; Craigen M; Waldram M; Mishra A; Dickson D; Wu F; Brewster M
J Hand Surg Am; 2020 Dec; 45(12):1187.e1-1187.e11. PubMed ID: 32861504
[TBL] [Abstract][Full Text] [Related]
10. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
Wei DH; Cantlon MB; Wakefield DB; Vitale MA
J Hand Surg Am; 2020 Oct; 45(10):989.e1-989.e10. PubMed ID: 32546304
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome of collagenase clostridium histolyticum treatment is independent of Dupuytren Diathesis Score.
VAN Nuffel M; Posthuma DE Boer J; Cootjans K; Borgers A; DE Smet L; Degreef I
Acta Orthop Belg; 2023 Jun; 89(2):233-240. PubMed ID: 37924539
[TBL] [Abstract][Full Text] [Related]
14. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
[No Abstract] [Full Text] [Related]
15. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
18. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
Skov ST; Bisgaard T; Søndergaard P; Lange J
J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Results of a Randomized, Controlled Trial of Collagenase Treatment Compared With Needle Fasciotomy for Dupuytren Contracture.
Byström M; Ibsen Sörensen A; Samuelsson K; Fridén JO; Strömberg J
J Hand Surg Am; 2022 Mar; 47(3):211-217. PubMed ID: 35074248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
